HKB's Mouse Experimental Autoimmune Uveitis Models provide pharmaceutical researchers with robust platforms for investigating sight-threatening ocular inflammation. Our validated rodent models utilize IRBP or S-antigen immunization to replicate key features of uveitis including retinal inflammation, iris involvement, and potential vision loss. These models support evaluation of corticosteroid-sparing agents, anti-TNF biologics, and novel immunomodulatory approaches targeting ocular immunity. Comprehensive endpoints include clinical ophthalmic scoring, fundoscopic assessment, histopathological analysis of retinal architecture and inflammatory infiltrates, and electroretinography where applicable.
HkeyBio is a China-based, globally-focused preclinical CRO dedicated exclusively to autoimmune and allergic diseases, with a unified service network across Asia, the Americas, Europe and Australia.